Jyothy Labs Limited announced its financial results for the quarter ended September 30, 2025 (Q2 FY26), posting a steady topline performance with consistent profitability driven by efficient cost management and strong performance across key product categories.
Revenue performance
The company’s revenue from operations stood at Rs 736.06 crore, compared to Rs 733.07 crore in Q2 FY25 — reflecting a 0.4% year-on-year growth, and a 2% sequential decline from Rs 751.21 crore in Q1 FY26.
Including other income of Rs 17 crore, total income for the quarter came in at Rs 753 crore, up from Rs 746 crore in the same period last year.
For the half year ended September 2025, Jyothy Labs recorded a total income of Rs 1,523.7 crore, compared to Rs 1,500.5 crore in the first half of FY25 — a 1.5% rise year-on-year.
Expense and margin analysis
Total expenses during Q2 FY26 stood at Rs 634.35 crore, compared to Rs 610.02 crore in Q2 FY25 — an increase of 4% YoY, reflecting higher material and employee costs.
Key expense components included:
- Cost of materials consumed: Rs 383.8 crore (up 11.2% YoY)
- Advertisement and sales promotion: Rs 61.47 crore (up 0.7% YoY)
- Employee benefit expenses: Rs 84.77 crore (up 5.2% YoY)
- Other expenses: Rs 89.18 crore (up 1.4% YoY)
Despite moderate inflationary pressures, operating margins remained healthy, supported by optimized production and improved sales mix.
Profit and tax
The company’s profit before tax (PBT) for Q2 FY26 stood at Rs 118.7 crore, compared to Rs 135.6 crore in Q2 FY25 — a 12.4% decline year-on-year, primarily due to increased costs and lower other income.
After accounting for tax expenses of Rs 30.93 crore, the net profit for the quarter stood at Rs 87.8 crore, compared to Rs 104.9 crore in Q2 FY25 — a 16.3% YoY decline.
For the half-year ended September 2025, Jyothy Labs posted a net profit of Rs 184.6 crore, compared to Rs 206.8 crore during the same period last year.
Financial summary (Rs crore)
| Particulars | Q2 FY26 | Q1 FY26 | Q2 FY25 | YoY % | QoQ % |
|---|---|---|---|---|---|
| Revenue from operations | 736.1 | 751.2 | 733.1 | +0.4% | -2.0% |
| Other income | 17.0 | 19.4 | 12.5 | +36.0% | -12.4% |
| Total income | 753.0 | 770.6 | 745.6 | +1.0% | -2.3% |
| Total expenses | 634.4 | 643.1 | 610.0 | +4.0% | -1.4% |
| Profit before tax | 118.7 | 127.5 | 135.6 | -12.4% | -6.9% |
| Net profit | 87.8 | 96.8 | 104.9 | -16.3% | -9.3% |
Outlook
Jyothy Labs continues to deliver steady financial performance despite moderate cost inflation. Focus remains on expanding its presence in mass and mid-premium categories under its flagship brands — including Ujala, Maxo, and Exo — supported by sustained investments in marketing and distribution.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
